Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Ulenistamab

😃Good
Catalog No. T78306Cas No. 2415259-90-2
Alias PBP1510, PBP 1510

Ulenistamab (PBP1510) is a first-in-class humanised IgG1 monoclonal antibody that specifically targets pancreatic adenocarcinoma upregulated factor (PAUF), Ulenistamab is extensively used in pancreatic cancer research to investigate PAUF-driven tumor progression, tumor microenvironment modulation, and antibody-based therapeutic strategies for pancreatic adenocarcinoma.

Ulenistamab

Ulenistamab

😃Good
Purity: 95%
Catalog No. T78306Alias PBP1510, PBP 1510Cas No. 2415259-90-2
Ulenistamab (PBP1510) is a first-in-class humanised IgG1 monoclonal antibody that specifically targets pancreatic adenocarcinoma upregulated factor (PAUF), Ulenistamab is extensively used in pancreatic cancer research to investigate PAUF-driven tumor progression, tumor microenvironment modulation, and antibody-based therapeutic strategies for pancreatic adenocarcinoma.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$289-In Stock
5 mg$753-In Stock
10 mg$1,180-In Stock
25 mg$1,770-In Stock
50 mg$2,380-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.4% (SDS-PAGE); 99.1% (SEC-HPLC)
Contact us for more batch information

Product Introduction

Bioactivity
Description
Ulenistamab (PBP1510) is a first-in-class humanised IgG1 monoclonal antibody that specifically targets pancreatic adenocarcinoma upregulated factor (PAUF), Ulenistamab is extensively used in pancreatic cancer research to investigate PAUF-driven tumor progression, tumor microenvironment modulation, and antibody-based therapeutic strategies for pancreatic adenocarcinoma.
In vitro
Ulenistamab (PBP1510) inhibits the proliferation of pancreatic cancer cell lines (CFPAC-1 and BxPC-3). Concurrently, there is a significant reduction in the migration and invasion of these cell lines [1].
In vivo
The pharmacokinetic (PK) profiles and immunogenicity of Ulenistamab (PBP1510) (up to 20 mg/kg) were examined in a single-dose study involving 6 monkeys. Systemic exposure in the monkey study was observed to increase in a dose-proportional manner at both low and high doses [1].
SynonymsPBP1510, PBP 1510
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
TargetPAUF
Chemical Properties
Molecular Weight147.63 kDa
Cas No.2415259-90-2
ColorTransparent
AppearanceLiquid
Antibody Information
IsotypeHuman IgG1 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 2 years, 4°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Ulenistamab | purchase Ulenistamab | Ulenistamab cost | order Ulenistamab | Ulenistamab in vivo | Ulenistamab in vitro | Ulenistamab molecular weight